Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
| Revenue (TTM) | $596.34M |
| Gross Profit (TTM) | $163.96M |
| EBITDA | $59.53M |
| Operating Margin | -7.19% |
| Return on Equity | -898.00% |
| Return on Assets | 1.99% |
| Revenue/Share (TTM) | $3.67 |
| Book Value | $-0.88 |
| Price-to-Book | 33.20 |
| Price-to-Sales (TTM) | 2.58 |
| EV/Revenue | 1.748 |
| EV/EBITDA | 1.72 |
| Quarterly Earnings Growth (YoY) | -38.10% |
| Quarterly Revenue Growth (YoY) | -79.10% |
| Shares Outstanding | $164.44M |
| Float | $141.47M |
| % Insiders | 5.08% |
| % Institutions | 69.66% |
Volatility is currently contracting
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
RALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, today commented on yesterday's announced voting results from Novavax's June 18th 2026 Annual Meeting of Stockholders.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) closed the most recent trading day at $9.13, moving 3.89% from the previous trading session.
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
